Literature DB >> 30802784

Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark.

Titus J Brinker1, Achim Hekler2, Axel Hauschild3, Carola Berking4, Bastian Schilling5, Alexander H Enk6, Sebastian Haferkamp7, Ante Karoglan8, Christof von Kalle2, Michael Weichenthal3, Elke Sattler4, Dirk Schadendorf9, Maria R Gaiser10, Joachim Klode9, Jochen S Utikal10.   

Abstract

BACKGROUND: Several recent publications have demonstrated the use of convolutional neural networks to classify images of melanoma at par with board-certified dermatologists. However, the non-availability of a public human benchmark restricts the comparability of the performance of these algorithms and thereby the technical progress in this field.
METHODS: An electronic questionnaire was sent to dermatologists at 12 German university hospitals. Each questionnaire comprised 100 dermoscopic and 100 clinical images (80 nevi images and 20 biopsy-verified melanoma images, each), all open-source. The questionnaire recorded factors such as the years of experience in dermatology, performed skin checks, age, sex and the rank within the university hospital or the status as resident physician. For each image, the dermatologists were asked to provide a management decision (treat/biopsy lesion or reassure the patient). Main outcome measures were sensitivity, specificity and the receiver operating characteristics (ROC).
RESULTS: Total 157 dermatologists assessed all 100 dermoscopic images with an overall sensitivity of 74.1%, specificity of 60.0% and an ROC of 0.67 (range = 0.538-0.769); 145 dermatologists assessed all 100 clinical images with an overall sensitivity of 89.4%, specificity of 64.4% and an ROC of 0.769 (range = 0.613-0.9). Results between test-sets were significantly different (P < 0.05) confirming the need for a standardised benchmark.
CONCLUSIONS: We present the first public melanoma classification benchmark for both non-dermoscopic and dermoscopic images for comparing artificial intelligence algorithms with diagnostic performance of 145 or 157 dermatologists. Melanoma Classification Benchmark should be considered as a reference standard for white-skinned Western populations in the field of binary algorithmic melanoma classification.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Artificial intelligence; Benchmark; Deep learning; Melanoma

Mesh:

Year:  2019        PMID: 30802784     DOI: 10.1016/j.ejca.2018.12.016

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  15 in total

Review 1.  Artificial Intelligence for Mental Health and Mental Illnesses: an Overview.

Authors:  Sarah Graham; Colin Depp; Ellen E Lee; Camille Nebeker; Xin Tu; Ho-Cheol Kim; Dilip V Jeste
Journal:  Curr Psychiatry Rep       Date:  2019-11-07       Impact factor: 5.285

2.  Classification of Basal Cell Carcinoma in Ex Vivo Confocal Microscopy Images from Freshly Excised Tissues Using a Deep Learning Algorithm.

Authors:  Mercedes Sendín-Martín; Manuel Lara-Caro; Ucalene Harris; Matthew Moronta; Anthony Rossi; Erica Lee; Chih-Shan Jason Chen; Kishwer Nehal; Julián Conejo-Mir Sánchez; José-Juan Pereyra-Rodríguez; Manu Jain
Journal:  J Invest Dermatol       Date:  2021-10-23       Impact factor: 7.590

Review 3.  Artificial intelligence approaches to predicting and detecting cognitive decline in older adults: A conceptual review.

Authors:  Sarah A Graham; Ellen E Lee; Dilip V Jeste; Ryan Van Patten; Elizabeth W Twamley; Camille Nebeker; Yasunori Yamada; Ho-Cheol Kim; Colin A Depp
Journal:  Psychiatry Res       Date:  2019-12-09       Impact factor: 3.222

Review 4.  Machine learning for precision dermatology: Advances, opportunities, and outlook.

Authors:  Ernest Y Lee; Nolan J Maloney; Kyle Cheng; Daniel Q Bach
Journal:  J Am Acad Dermatol       Date:  2020-07-06       Impact factor: 11.527

5.  Artificial intelligence (AI) in medicine as a strategic valuable tool.

Authors:  Andreas Larentzakis; Nik Lygeros
Journal:  Pan Afr Med J       Date:  2021-02-17

6.  Predicting the clinical management of skin lesions using deep learning.

Authors:  Kumar Abhishek; Jeremy Kawahara; Ghassan Hamarneh
Journal:  Sci Rep       Date:  2021-04-08       Impact factor: 4.379

7.  Effects of Label Noise on Deep Learning-Based Skin Cancer Classification.

Authors:  Achim Hekler; Jakob N Kather; Eva Krieghoff-Henning; Jochen S Utikal; Friedegund Meier; Frank F Gellrich; Julius Upmeier Zu Belzen; Lars French; Justin G Schlager; Kamran Ghoreschi; Tabea Wilhelm; Heinz Kutzner; Carola Berking; Markus V Heppt; Sebastian Haferkamp; Wiebke Sondermann; Dirk Schadendorf; Bastian Schilling; Benjamin Izar; Roman Maron; Max Schmitt; Stefan Fröhling; Daniel B Lipka; Titus J Brinker
Journal:  Front Med (Lausanne)       Date:  2020-05-06

8.  Web-based study on Chinese dermatologists' attitudes towards artificial intelligence.

Authors:  Changbing Shen; Chengxu Li; Feng Xu; Ziyi Wang; Xue Shen; Jing Gao; Randy Ko; Yan Jing; Xiaofeng Tang; Ruixing Yu; Junhu Guo; Feng Xu; Rusong Meng; Yong Cui
Journal:  Ann Transl Med       Date:  2020-06

9.  Stress testing reveals gaps in clinic readiness of image-based diagnostic artificial intelligence models.

Authors:  Albert T Young; Kristen Fernandez; Jacob Pfau; Rasika Reddy; Nhat Anh Cao; Max Y von Franque; Arjun Johal; Benjamin V Wu; Rachel R Wu; Jennifer Y Chen; Raj P Fadadu; Juan A Vasquez; Andrew Tam; Michael J Keiser; Maria L Wei
Journal:  NPJ Digit Med       Date:  2021-01-21

Review 10.  Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review.

Authors:  Julia Höhn; Achim Hekler; Eva Krieghoff-Henning; Jakob Nikolas Kather; Jochen Sven Utikal; Friedegund Meier; Frank Friedrich Gellrich; Axel Hauschild; Lars French; Justin Gabriel Schlager; Kamran Ghoreschi; Tabea Wilhelm; Heinz Kutzner; Markus Heppt; Sebastian Haferkamp; Wiebke Sondermann; Dirk Schadendorf; Bastian Schilling; Roman C Maron; Max Schmitt; Tanja Jutzi; Stefan Fröhling; Daniel B Lipka; Titus Josef Brinker
Journal:  J Med Internet Res       Date:  2021-07-02       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.